 |
인쇄하기
취소
|
KFDA requires additional warning for OTC pain relievers
The Korea Food and Drug Administration has recently issued an additional warning that requires manufacturers of OTC pain relievers and fever reducers to take preventive measures about potential safety risks associated with overdose of these popular drugs.
Products covered by the KFDA action include isopropylantipyrine (IPA), a substance that has been linked to side effects including hemorrha...
Products covered by the KFDA action include isopropylantipyrine (IPA), a substance that has been linked to side effects including hemorrha...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.